the srs-a antagonist , fpl 55712 , reduced the increase in tracheal extravascular albumin content evoked by ltc4 , ltd4 , and lte4 but failed to significantly reduce the tracheal microvascular permeability response associated with local anaphylaxis .
C0038091
srs-a
C0023544
ltd4